Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  vismodegib
Find trials that include:  Any drugs shown
Results 1-11 of 11 for your search:
Start Over
Vismodegib in Treating Patients with Locally Advanced or Recurrent Orbital or Periocular Basal Cell Cancer
Status: Active
Phase: Phase IV
Type: Treatment
Age: 18 and over
Trial IDs: UMCC 2014.022, NCI-2015-00927, HUM00082579, ML29160, NCT02436408
Radiation Therapy and Vismodegib in Treating Patients With Locally Advanced Head and Neck Cancer
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: CC #122011, NCI-2013-00871, 122011, NCT01835626
A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf, and Erivedge Treatment Targeted Against Certain Mutations in Cancer Patients
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: ML28897, NCI-2014-01811, NCT02091141
NCI-MATCH: Targeted Therapy Directed by Genetic Testing in Treating Patients with Advanced Refractory Solid Tumors or Lymphomas
Status: Temporarily closed
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: EAY131, NCI-2015-00054, EAY131-A, EAY131-B, EAY131-E, EAY131-F, EAY131-G, EAY131-H, EAY131-I, EAY131-N, EAY131-P, EAY131-Q, EAY131-R, EAY131-S1, EAY131-S2, EAY131-T, EAY131-U, EAY131-V, EAY131-X, NCT02465060
Vismodegib and FAK Inhibitor GSK2256098 in Treating Patients with Progressive Meningiomas
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: A071401, NCI-2015-00546, NCI-2015-00501, NCT02523014
Sirolimus and Vismodegib in Treatment of Patients with Solid Tumors or Pancreatic Cancer That is Metastatic or Cannot Be Removed by Surgery
Status: Temporarily closed
Phase: Phase I
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Age: 18 and over
Trial IDs: MC1111, NCI-2011-03809, NCT01537107
Photodynamic Therapy and Vismodegib in Treating Patients with Multiple Basal Cell Cancers
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 1511201549, NCI-2016-00096, ML28849, NCT02639117
Pembrolizumab with or without Vismodegib in Treating Skin Basal Cell Cancer That Is Metastatic or Cannot Be Removed by Surgery
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: SKIN0031, NCI-2015-01869, 350, NCT02690948
Clinical and Molecular Risk-Directed Craniospinal Irradiation and Combination Chemotherapy in Treating Younger Patients with Newly Diagnosed Medulloblastoma
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 3 to 21 at diagnosis
Trial IDs: SJMB12, NCI-2013-01125, NCT01878617
Levocarnitine in Treating Patients with Vismodegib-Associated Muscle Spasms
Status: Active
Phase: No phase specified
Type: Supportive care
Age: 18 and over
Trial IDs: SKIN0018, NCI-2013-01269, 5136, IRB-27478, NCT01893892
Vismodegib in Treating Patients with Steroid-Refractory Chronic Graft-versus-Host Disease
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology, Supportive care
Age: 18 and over
Trial IDs: 84584, NCI-2014-02672, IIT 9664, 9664, NCT02337517
Start Over